MedTrace Logo

Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia

NCT00567671 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2010-09-02

No results posted yet for this study

Summary

Prospective, randomized, single site study to determine the safety and effectiveness of performing corneal collagen cross-linking (CCCL)using riboflavin and UVA light in eyes with corneal ectasia or progressive keratoconus.

Conditions

  • Progressive Keratoconus
  • Corneal Ectasia

Interventions

PROCEDURE

Corneal collagen

Corneal collagen cross-linking with riboflavin/UVA light

PROCEDURE

Sham comparator

Sham treatment

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • R. Doyle Stulting, MD, PhD · Emory Vision; Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567671 on ClinicalTrials.gov